Morgan Stanley
STIM icon

Morgan Stanley’s Neuronetics STIM Stock Holding History

Morgan Stanley’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.8K Buy
62,893
+22,820
+57% +$33.2K ﹤0.01% 6337
2026
Q1 		$58.1K Sell
40,073
-76,358
-66% -$121K ﹤0.01% 6371
2025
Q4 		$161K Sell
116,431
-359,279
-76% -$752K ﹤0.01% 6010
2025
Q3 		$1.3M Sell
475,710
-170,330
-26% -$605K ﹤0.01% 5036
2025
Q2 		$2.25M Buy
646,040
+574,770
+806% +$2.27M ﹤0.01% 4628
2025
Q1 		$262K Buy
71,270
+70,480
+8,922% +$257K ﹤0.01% 5623
2024
Q4 		$1.27K Hold
790
– – ﹤0.01% 7245
2024
Q3 		$600 Hold
790
– – ﹤0.01% 7280
2024
Q2 		$1.42K Sell
790
-13,455
-94% -$38.8K ﹤0.01% 7113
2024
Q1 		$67.8K Buy
14,245
+11,410
+402% +$40.1K ﹤0.01% 6120
2023
Q4 		$8.22K Buy
2,835
+182
+7% +$287 ﹤0.01% 6714
2023
Q3 		$3.58K Sell
2,653
-17,328
-87% -$30.4K ﹤0.01% 6992
2023
Q2 		$43K Sell
19,981
-133,635
-87% -$324K ﹤0.01% 6269
2023
Q1 		$447K Sell
153,616
-284,843
-65% -$1.44M ﹤0.01% 5322
2022
Q4 		$3.01M Buy
438,459
+401,126
+1,074% +$1.89M ﹤0.01% 4165
2022
Q3 		$119K Sell
37,333
-26,967
-42% -$98K ﹤0.01% 5991
2022
Q2 		$208K Buy
64,300
+51,997
+423% +$151K ﹤0.01% 5876
2022
Q1 		$37K Buy
12,303
+4,114
+50% +$13.9K ﹤0.01% 6847
2021
Q4 		$35K Sell
8,189
-135,773
-94% -$665K ﹤0.01% 6975
2021
Q3 		$944K Buy
143,962
+88,810
+161% +$852K ﹤0.01% 5082
2021
Q2 		$883K Sell
55,152
-233,295
-81% -$3.22M ﹤0.01% 5153
2021
Q1 		$3.57M Buy
288,447
+268,754
+1,365% +$4.12M ﹤0.01% 3758
2020
Q4 		$219K Sell
19,693
-45,161
-70% -$339K ﹤0.01% 5544
2020
Q3 		$315K Buy
64,854
+7,723
+14% +$29.3K ﹤0.01% 4877
2020
Q2 		$110K Buy
57,131
+3,041
+6% +$6.24K ﹤0.01% 5361
2020
Q1 		$102K Sell
54,090
-360,883
-87% -$1.13M ﹤0.01% 5175
2019
Q4 		$1.86M Buy
414,973
+233,994
+129% +$1.45M ﹤0.01% 4100
2019
Q3 		$1.5M Buy
180,979
+70,298
+64% +$768K ﹤0.01% 4028
2019
Q2 		$1.39M Buy
110,681
+108,794
+5,765% +$1.54M ﹤0.01% 4038
2019
Q1 		$29K Sell
1,887
-7,906
-81% -$131K ﹤0.01% 5892
2018
Q4 		$189K Sell
9,793
-320
-3% -$7.02K ﹤0.01% 5308
2018
Q3 		$324K Buy
+10,113
New +$307K ﹤0.01% 5229

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley's STIM Position: Q2 2026 in Review

Morgan Stanley increased its Neuronetics (STIM) stake by 57% in Q2 2026, buying an estimated $33.2K and bringing the position to 62,893 shares worth $81.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6337.

Morgan Stanley first reported a position in STIM in Q3 2018 and has held it in 32 quarters since. The position peaked at $3.57M in Q1 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Morgan Stanley held 62,893 shares of Neuronetics worth $81.8K as of Q2 2026.
  • Morgan Stanley bought 22,820 Neuronetics shares in Q2 2026, an estimated $33.2K.
  • Neuronetics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6337 holding.
  • Morgan Stanley first reported a position in Neuronetics in Q3 2018 and has held it in 32 quarters since.
  • Morgan Stanley's Neuronetics position peaked at $3.57M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.